Can quality of life assessments differentiate heterogeneous cancer patients?

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  McCabe, Ryan M ^a,c   Grutsch, James F ^a,b   Nutakki, Swetha B ^a   Braun, Donald P ^a   Markman, Maurie ^a  

^a CANCER TREATMENT CENTERS OF AMERICA   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c AMERICAN COLLEGE OF SURGEONS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER REGISTRY; CANCER STAGING; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; DYSPNEA; FATIGUE; FEMALE; HUMAN; LOSS OF APPETITE; MAJOR CLINICAL STUDY; MALE; PAIN; PATIENT ASSESSMENT; QUALITY OF LIFE; SCORING SYSTEM; SEX DIFFERENCE; VALIDATION STUDY; AGED; MIDDLE AGED; NEOPLASM; PATHOPHYSIOLOGY; PSYCHOLOGY;

AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; QUALITY OF LIFE;

EID: 84903386122     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099445     Document Type: Article

References (38)

1. Bottomley A (2002) The Cancer Patient and Quality of Life. The Oncologist 7: 120-125. Available: http://theoncologist.alphamedpress.org/cgi/content/ abstract/7/2/120. Accessed 19 January 2012.
2. Ferrans CE (2007) Differences in what quality-of-life instruments measure. Journal of the National Cancer Institute Monographs: 22-26. Available: http://www.ncbi.nlm.nih.gov/pubmed/17951227.
3. Quinten C, Maringwa J, Gotay CC, Martinelli F, Coens C, et al. (2011) Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival. Journal of the National Cancer Institute 103: 1851-1858. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 3243678&tool=pmcentrez&rendertype=abstract.
4. Cocks K, King MT, Velikova G, Martyn St-James M, Fayers PM, et al. (2011) Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. Journal of Clinical Oncology 29: 89-96. Available: http://www.ncbi.nlm.nih.gov/pubmed/21098316.
5. Halyard MY, Ferrans CE (2008) Quality-of-Life assessment for routine oncology clinical practice. The journal of supportive oncology 6: 221-233. Available: http://www.ncbi.nlm.nih.gov/pubmed/18551858.
6. Velikova G, Stark D, Selby P (1999) Quality of life instruments in oncology. European journal of cancer (Oxford, England: 1990) 35: 1571-1580. Available: http://www.ncbi.nlm.nih.gov/pubmed/10673964. Accessed 2 August 2012.
7. Sloan JA (2003) Assessing the clinical significance of Quality of Life (QOL) measures. Society of Clinical Research Associates: 23-24. Available: http://www.socra.org/pdf/200311-AssessingClinSigQualOfLife.pdf.
8. Unger JM, Barlow WE, Martin DP, Ramsey SD, LeBlanc M, et al. (2014) Comparison of Survival Outcomes Among Cancer Patients Treated In and Out of Clinical Trials. JNCI J Natl Cancer Inst.
9. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, et al. (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. Journal Of The National Cancer Institute 85: 365-376. Available: http://jnci.oxfordjournals.org/content/85/5/365.short.
10. Bjordal K, De Graeff A, Fayers PM, Hammerlid E, Van Pottelsberghe C, et al. (2000) A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. European Journal of Cancer 36: 1796-1807. (Pubitemid 30639500)
11. Osoba D, Rodrigues G, Myles J, Zee B, Pater J (1998) Interpreting the significance of changes in health-related quality-of-life scores. Journal of Clinical Oncology 16: 139-144. Available: http://www.ncbi.nlm.nih.gov/entrez/ query.fcgi?cmd =Retrieve&db =PubMed&dopt =Citation&list-uids = 9440735.
12. Cocks K, King MT, Velikova G, Fayers PM, Brown JM (2008) Quality, interpretation and presentation of European Organisation for Research and Treatment of Cancer quality of life questionnaire core 30 data in randomised controlled trials. European Journal of Cancer 44: 1793-1798. Available: http://www.ncbi.nlm.nih.gov/pubmed/18599286.
13. King MT (1996) The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Quality of life research an international journal of quality of life aspects of treatment care and rehabilitation 5: 555-567. Available: http://www.ncbi.nlm.nih.gov/pubmed/8993101.
14. Osoba D, Aaronson N, Zee B, Sprangers M, Te Velde A (1997) Modification of the EORTC QLQ-C30 (version 2.0) based on content validity and reliability testing in large samples of patients with cancer. Quality of life research 6: 103-108. Available: http://www.ncbi.nlm.nih.gov/pubmed/9161109.
15. Bowling A (2001) Measuring disease: a review of disease-specific quality of life measurement scales. Sociology of Health and Illness 18: 395 pp. Available: http://eprints.kingston.ac.uk/17298/.
16. Guyatt GH, Feeny DH, Patrick DL (1993) Measuring health-related quality of life. Annals of Internal Medicine 118: 622-629. Available: http://www.ncbi.nlm.nih.gov/pubmed/8452328.
17. Katz JN, Larson MG, Phillips CB, Fossel AH, Liang MH (1992) Comparative measurement sensitivity of short and longer health status instruments. Medical Care 30: 917-925. Available: http://www.ncbi.nlm.nih.gov/pubmed/1405797.
18. Norman GR, Sloan JA, Wyrwich KW (2003) Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Medical Care 41: 582-592. Available: http://journals.lww.com/ lwwmedicalcare/Abstract/2003/05000/Interpretation-of-Changes-in-Health-related. 4.aspx.
19. Pickard AS, Neary MP, Cella D (2010) Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health and Quality of Life Outcomes 8: 4. Available: http://ovidsp.ovid.com/ovidweb.cgi?T = JS&PAGE =reference&D = medl&NEWS=N&AN= 18154669.
20. Cella D, Hahn EA, Dineen K (2002) Meaningful change in cancer-specific quality of life scores: differences between improvement and worsening. Quality of life research an international journal of quality of life aspects of treatment care and rehabilitation 11: 207-221. Available: http://www.ncbi.nlm. nih.gov/pubmed/12074259.
21. Maringwa J, Quinten C, King M, Ringash J, Osoba D, et al. (2011) Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials. Supportive care in cancer official journal of the Multinational Association of Supportive Care in Cancer 19: 1753-1760. Available: http://aithon.ngcsn.net/netacgi/getref2.pl?ref = P-20886240.
22. Scott NW, Fayers PM, Aaronson NK, Bottomley A, Graeff A de, et al. (2008) EORTC QLQ-C30 Reference Values. Available: http://groups.eortc.be/qol/ downloads/reference-values-manual2008.pdf.
23. Van De Poll-Franse L V, Mols F, Gundy CM, Creutzberg CL, Nout RA, et al. (2011) Normative data for the EORTC QLQ-C30 and EORTC-sexuality items in the general Dutch population. European Journal of Cancer 47: 667-675.
24. Jordhoy MS, Fayers P, Loge JH, Saltnes T, Ahlner-Elmqvist M, et al. (2001) Quality of life in advanced cancer patients: the impact of sociodemographic and medical characteristics. British Journal of Cancer 85: 1478-1485. Available: http://dx.doi.org/10.1054/bjoc.2001.2116.
25. Tishelman C, Petersson L-M, Degner LF, Sprangers MAG (2007) Symptom prevalence, intensity, and distress in patients with inoperable lung cancer in relation to time of death. Journal of Clinical Oncology 25: 5381-5389. Available: http://www.ncbi.nlm.nih.gov/pubmed/18048819.
26. Lee YT (1983) Breast carcinoma: pattern of metastasis at autopsy. Journal of surgical oncology 23: 175-180.
27. Conroy T, Desseigne F, Ychou M, Bouché O, Guimbaud R, et al. (2011) FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. The New England Journal of Medicine 365: 1817-1825. Available: http://www.ncbi.nlm.nih. gov/pubmed/21561347.
28. Hjermstad MJ, Fayers PM, Bjordal K, Kaasa S (1998) Using reference data on quality of life - the importance of adjusting for age and gender, exemplified by the EORTC QLQ-C30 (+3). European Journal of Cancer 34: 1381-1389. Available: http://linkinghub.elsevier.com/retrieve/pii/S0959804998001361.
29. Visser MRM, Oort FJ, Sprangers MAG (2005) Methods to detect response shift in quality of life data: a convergent validity study. Quality of life research 14: 629-639. Available: http://www.ncbi.nlm.nih.gov/pubmed/16022057.
30. Cohen S, Pressman SD (2006) Positive Affect and Health. Current Directions in Psychological Science 15: 122-125. Available: http://cdp.sagepub. com/lookup/doi/10.1111/j.0963-7214.2006.00420.x.
31. Grutsch JF, Ferrans C, Wood PA, Du-Quiton J, Quiton DFT, et al. (2011) The association of quality of life with potentially remediable disruptions of circadian sleep/activity rhythms in patients with advanced lung cancer. BMC Cancer 11: 193. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi? artid =3114794&tool =pmcentrez&rendertype = abstract.
32. Du-Quiton J, Wood PA, Burch JB, Grutsch JF, Gupta D, et al. (2010) Actigraphic assessment of daily sleep-activity pattern abnormalities reflects self-assessed depression and anxiety in outpatients with advanced non-small cell lung cancer. Psycho-Oncology 19: 180-189. Available: http://dx.doi.org/10.1002/ pon.1539.
33. Gordon JS (2008)Mind-body medicine and cancer. Hematology/oncology clinics of North America 22: 683-708. Available: http://www.sciencedirect.com/ science/article/B7RM3-4T0NT9M-C/2/0a344ee66b1376ccaaea5455bc42c51f.
34. Rabkin JG, McElhiney M, Moran P, Acree M, Folkman S (2009) Depression, distress and positive mood in late-stage cancer: a longitudinal study. Psychooncology 18: 79-86. Available: http://www.ncbi.nlm.nih.gov/pubmed/ 18613295. Accessed 19 January 2012.
35. Sprangers MAG, Sloan JA, Barsevick A, Chauhan C, Dueck AC, et al. (2010) Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes. Quality of life research 19: 1395-1403. Available: http://www.ncbi.nlm.nih.gov/pubmed/20945161.
36. Lis CG, Rodeghier M, Gupta D (2009) Distribution and determinants of patient satisfaction in oncology: A review of the literature. Patient preference and adherence 3: 287-304.
37. Velikova G, Keding A, Harley C, Cocks K, Booth L, et al. (2010) Patients report improvements in continuity of care when quality of life assessments are used routinely in oncology practice: Secondary outcomes of a randomised controlled trial. European Journal of Cancer. Vol. 46. pp. 2381-2388.
38. Wilson IB, Cleary PD (1995) Linking Clinical Variables With Health-Related Quality of Life. The Journal Of The American Medical Association 273: 59-65. Available: http://jama.ama-assn.org/content/273/1/59.short.